SUMMARY To evaluate the addition of hepatitis vaccine to health schemes for hospital workers in Zimbabwe we undertook a cross sectional study of viral markers in 226 hospital workers and compared the results with 97 volunteer blood donor controls. One hundred and thirty one (58%) hospital workers had hepatitis markers compared with 45 (46%) of the donor group. Racial group was the strongest risk factor. Blacks were 70% more likely to have markers than whites. This racial difference was not explained by job status or patient contact.
Hospital workers in contact with patients or blood products are at an increased risk of becoming infected with hepatitis B virus (HBV).' Some epidemiological studies in the West have shown this risk to be three to five fold higher than that of volunteer blood donors," other studies have shown no significant difference in the prevalence of HBV markers between the two groups." 12 Protection against this occupational hazard became possible in 1981 when the hepatitis vaccine was licensed for commercial production and sale. As many as 10% of HBV infected patients may go on to become chronic carriers of the virus, with a risk ofchronic liver disease, cirrhosis, and more rarely, hepatocellular carcinoma. Vaccination of high risk populations is therefore prudent and should be included in health schemes for workers if it can be shown that their jobs place them at increased risk of infection.
Most Western countries currently recommend the vaccine for hospital workers,5 as does the World Health Organisation.6 Unfortunately, the vaccine currently used is derived from plasma and is expensive. The current cost in Zimbabwe is Z$100 for each vaccine.
Recent studies have shown that the prevalence of At present, the risk of HBV infection among hospital workers in Zimbabwe is unknown. We undertook a cross sectional study of a group of hospital workers and volunteer blood donors to determine whether hospital workers were at greater risk, and, if so, whether subgroups of hospital workers at particularly high risk could be identified.
Material and methods
The population studied were employees of Parirenyatwa Hospital, a government referral hospital in Harare. Employee volunteers (n = 226) were drawn from two inpatient wards (n = 58), the outpatient department (n = 25), the mortuary (n = 7), administration (n = 5), pharmacy (n = 19), and kitchen staff (n = 112). The Other limitations of this study deserve mention. The hospital group was selected from various parts of the hospital on a volunteer basis. It is difficult to tell what sort of bias might have been introduced by the nonrandom selection of this group. We did not examine some groups of hospital workers, such as laboratory workers, who may be at increased risk. Finally, we did not collect information on occupational status in the donor control group. We were able to examine this risk factor as a possible "explanation" for the observed racial difference in HBV status only within the hospital group. Our serological data show that previous HBV infection was common among blacks in both the donor and the hospital groups. This risk does not seem to be related to hospital work. For this reason, in the absence of data which show a risk of HBV infection associated with hospital work, routine hepatitis B vaccination of hospital workers is too costly to be justified at this time.
